Clinical Trials List
Protocol NumberCBEZ235C2201
2011-06-01 - 2014-11-04
Phase II
Terminated3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ting-Chang Chang Division of Obstetrics & Gynecology
- 翁世樺 Division of Others
- Tzu-I Wu Division of Obstetrics & Gynecology
- 陳俞叡 Division of Radiology
- Angel Chao Division of Obstetrics & Gynecology
- 邱健泰 Division of Obstetrics & Gynecology
- Min-Yu Chen Division of Obstetrics & Gynecology
- 饒玫珊 Division of Obstetrics & Gynecology
- Huei-Jean Huang Division of Obstetrics & Gynecology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- 黃寬仁 Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
140 participants
